네오지노믹스(주)
DE ˙ DB ˙ US64049M2098
€8.62 ↑0.03 (0.35%)
2026-06-04
주가
SecurityDE:NG9 / NeoGenomics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership225,178 shares
Latest Disclosed Value $ 2,648,093
Barclays Plc reports 72.05% decrease in ownership of NG9 / NeoGenomics, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 225,178 shares of NeoGenomics, Inc. (DE:NG9) valued at $2,341,851 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 805,555 shares of NeoGenomics, Inc.. This represents a change in shares of -72.05% during the quarter. The current value of the position is $1,941,034 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F NEOGENOMICS COM 64049M209 225,178 -580,377 -72.05 2,648 -57.41 0.0006
2026-03-31 2025-09-30 13F/A-3 NEOGENOMICS COM 64049M209 805,555 541,677 205.28 6,219 222.51 0.0013
2026-03-19 2025-09-30 13F/A-2 NEOGENOMICS COM 64049M209 230,901 -32,977 3,406 0.0009
2025-11-12 2025-09-30 13F NEOGENOMICS COM 64049M209 805,555 541,677 6,219 0.0013
2026-02-27 2025-06-30 13F/A-2 NEOGENOMICS COM 64049M209 263,878 82,212 45.25 1,929 11.83 0.0004
2025-08-14 2025-06-30 13F/A-1 NEOGENOMICS COM 64049M209 263,878 82,212 2 0.0004
2025-08-13 2025-06-30 13F NEOGENOMICS COM 64049M209 263,878 82,212 2 0.0001
2026-03-17 2025-03-31 13F/A-1 NEOGENOMICS COM 64049M209 181,666 -57,772 -24.13 1,724 -56.30 0.0005
2025-05-15 2025-03-31 13F NEOGENOMICS COM 64049M209 181,666 -57,772 2 0.0005
2026-03-19 2024-12-31 13F/A-1 NEOGENOMICS COM 64049M209 239,438 8,537 3.70 3,946 15.86 0.0011
2025-02-13 2024-12-31 13F NEOGENOMICS COM 64049M209 239,438 8,537 4 0.0011
2026-03-31 2024-09-30 13F/A-2 NEOGENOMICS COM 64049M209 230,901 170,218 280.50 3,406 304.88 0.0009
2024-11-19 2024-09-30 13F/A-1 NEOGENOMICS COM 64049M209 230,901 170,218 3 0.0009
2024-11-15 2024-09-30 13F NEOGENOMICS COM 64049M209 230,901 170,218 3 0.0003
2026-03-23 2024-06-30 13F/A-1 NEOGENOMICS COM 64049M209 60,683 -69,856 -53.51 842 -59.02 0.0003
2024-08-14 2024-06-30 13F NEOGENOMICS COM 64049M209 60,683 -69,856 1 0.0003
2026-03-24 2024-03-31 13F/A-1 NEOGENOMICS COM 64049M209 130,539 -78,788 -37.64 2,052 -39.40 0.0007
2024-05-15 2024-03-31 13F NEOGENOMICS COM 64049M209 130,539 -78,788 2 0.0007
2026-03-25 2023-12-31 13F/A-1 NEOGENOMICS COM 64049M209 209,327 139,461 199.61 3,387 294.18 0.0012
2024-02-15 2023-12-31 13F NEOGENOMICS COM 64049M209 209,327 139,461 3 0.0012
2026-03-26 2023-09-30 13F/A-1 NEOGENOMICS COM 64049M209 69,866 -3,543 -4.83 859 -27.14 0.0005
2023-11-07 2023-09-30 13F NEOGENOMICS COM 64049M209 69,866 -3,543 1 0.0005
2026-03-30 2023-06-30 13F/A-2 NEOGENOMICS COM 64049M209 73,409 8,083 12.37 1,180 3.69 0.0007
2023-09-20 2023-06-30 13F/A-1 NEOGENOMICS COM 64049M209 73,409 8,083 1 0.0007
2023-08-03 2023-06-30 13F NEOGENOMICS COM 64049M209 73,409 8,083 1 0.0007
2026-03-30 2023-03-31 13F/A-1 NEOGENOMICS COM 64049M209 65,326 -26,516 -28.87 1,137 34.08 0.0005
2023-05-04 2023-03-31 13F NEOGENOMICS COM 64049M209 65,326 -26,516 1 0.0005
2026-03-30 2022-12-31 13F/A-1 NEOGENOMICS COM 64049M209 91,842 49,951 119.24 849 134.90 0.0004
2023-02-13 2022-12-31 13F NEOGENOMICS COM 64049M209 91,842 49,951 1 0.0004
2022-11-03 2022-09-30 13F NEOGENOMICS COM 64049M209 41,891 -1,596,434 -97.44 361 -97.30 0.0004
2022-08-12 2022-06-30 13F NEOGENOMICS COM 64049M209 1,638,325 1,532,113 1,442.50 13,353 935.12 0.0082
2022-05-16 2022-03-31 13F NEOGENOMICS COM 64049M209 106,212 -50,288 -32.13 1,290 -75.85 0.0010
2022-02-23 2021-12-31 13F/A-1 NEOGENOMICS COM 64049M209 156,500 18,587 13.48 5,341 -19.71 0.0020
2022-02-14 2021-12-31 13F NEOGENOMICS COM 64049M209 156,500 18,587 5,341 0.0020
2021-11-09 2021-09-30 13F NEOGENOMICS COM 64049M209 137,913 13,691 11.02 6,652 18.57 0.0030
2021-08-13 2021-06-30 13F NEOGENOMICS COM 64049M209 124,222 -31,408 -20.18 5,610 -25.25 0.0027
2021-05-13 2021-03-31 13F NEOGENOMICS COM 64049M209 155,630 20,022 14.76 7,505 2.79 0.0040
2021-02-11 2020-12-31 13F NEOGENOMICS COM 64049M209 135,608 -7,016 -4.92 7,301 38.78 0.0039
2020-11-12 2020-09-30 13F NEOGENOMICS COM 64049M209 142,624 27,798 24.21 5,261 47.91 0.0031
2020-08-12 2020-06-30 13F NEOGENOMICS COM 64049M209 114,826 13,339 13.14 3,557 26.95 0.0027
2020-05-13 2020-03-31 13F NEOGENOMICS COM 64049M209 101,487 -45,895 -31.14 2,802 -35.00 0.0022
2020-02-10 2019-12-31 13F NEOGENOMICS COM 64049M209 147,382 12,043 8.90 4,311 66.51 0.0024
2019-11-15 2019-09-30 13F/A-1 NEOGENOMICS COM 64049M209 135,339 28,265 26.40 2,589 10.22 0.0016
2019-11-14 2019-09-30 13F NEOGENOMICS COM 64049M209 135,339 28,265 2,589 598.5797
2019-08-14 2019-06-30 13F NEOGENOMICS COM 64049M209 107,074 42,517 65.86 2,349 77.95 0.0014
2019-05-15 2019-03-31 13F NEOGENOMICS COM 64049M209 64,557 -52,461 -44.83 1,320 -10.51 0.0009
2019-02-14 2018-12-31 13F NEOGENOMICS COM 64049M209 117,018 51,006 77.27 1,475 45.61 0.0011
2018-11-14 2018-09-30 13F NEOGENOMICS COM 64049M209 66,012 1,389 2.15 1,013 19.74 0.0007
2018-08-14 2018-06-30 13F NEOGENOMICS COM 64049M209 64,623 11,328 21.26 846 94.48 0.0007
2018-05-15 2018-03-31 13F NEOGENOMICS COM 64049M209 53,295 42,314 385.34 435 343.88 0.0003
2018-02-14 2017-12-31 13F NEOGENOMICS COM 64049M209 10,981 -25,912 -70.24 98 -76.10 0.0001
2017-11-14 2017-09-30 13F NEOGENOMICS COM 64049M209 36,893 34,952 1,800.72 410 2,311.76 0.0004
2017-08-14 2017-06-30 13F NEOGENOMICS COM 64049M209 1,941 -51,853 -96.39 17 -95.99 0.0000
2017-05-15 2017-03-31 13F NEOGENOMICS COM 64049M209 53,794 -5,937 -9.94 424 -17.03 0.0005
2017-02-14 2016-12-31 13F NEOGENOMICS COM 64049M209 59,731 -5,693 -8.70 511 -5.02 0.0006
2016-11-14 2016-09-30 13F NEOGENOMICS COM 64049M209 65,424 62,370 2,042.24 538 2,141.67 0.0006
2016-08-12 2016-06-30 13F NEOGENOMICS COM 64049M209 3,054 -16,646 -84.50 24 -79.66 0.0000
2016-05-16 2016-03-31 13F NEOGENOMICS COM 64049M209 19,700 -45,529 -69.80 118 -74.18 0.0002
2016-02-12 2015-12-31 13F NEOGENOMICS COM 64049M209 65,229 64,949 23,196.07 457 45,600.00 0.0006
2015-11-13 2015-09-30 13F NEOGENOMICS COM 64049M209 280 -744 -72.66 1 -80.00 0.0000
2015-08-14 2015-06-30 13F NEOGENOMICS COM 64049M209 1,024 1,024 0.00 5 0.0000
2015-02-13 2014-12-31 13F NEOGENOMICS COM 64049M209 0 -136 -100.00 0 -100.00
2014-11-14 2014-09-30 13F NEOGENOMICS COM 64049M209 136 73 115.87 1 0.0000
2014-08-14 2014-06-30 13F NEOGENOMICS COM 64049M209 63 -1,227 -95.12 0 -100.00
2014-05-15 2014-03-31 13F NEOGENOMICS COM 64049M209 1,290 562 77.20 4 100.00 0.0000
2014-02-13 2013-12-31 13F NEOGENOMICS COM 64049M209 728 -506 -41.00 2 -50.00 0.0000
2013-11-14 2013-09-30 13F NEOGENOMICS COM 64049M209 1,234 -492 -28.51 4 -42.86 0.0000
2013-08-14 2013-06-30 13F NEOGENOMICS COM 64049M209 1,726 1,726 7 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.